Kiniksa Pharmaceuticals International (KNSA) Amortizatization of Intangibles (2021 - 2025)
Kiniksa Pharmaceuticals International (KNSA) has disclosed Amortizatization of Intangibles for 5 consecutive years, with $930000.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles rose 213.55% year-over-year to $930000.0, compared with a TTM value of $916000.0 through Dec 2025, up 307.71%, and an annual FY2025 reading of $916000.0, up 307.71% over the prior year.
- Amortizatization of Intangibles was $930000.0 for Q4 2025 at Kiniksa Pharmaceuticals International, up from -$603000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.2 million in Q2 2023 and bottomed at -$1.4 million in Q3 2023.
- Average Amortizatization of Intangibles over 5 years is $48050.0, with a median of -$30500.0 recorded in 2021.
- Peak annual rise in Amortizatization of Intangibles hit 1615.79% in 2023, while the deepest fall reached 1310.92% in 2023.
- Year by year, Amortizatization of Intangibles stood at -$47000.0 in 2021, then skyrocketed by 531.91% to $203000.0 in 2022, then skyrocketed by 45.81% to $296000.0 in 2023, then tumbled by 376.69% to -$819000.0 in 2024, then soared by 213.55% to $930000.0 in 2025.
- Business Quant data shows Amortizatization of Intangibles for KNSA at $930000.0 in Q4 2025, -$603000.0 in Q3 2025, and $844000.0 in Q2 2025.